← Back to Clinical Trials
Recruiting NCT06930443

NCT06930443 Oxygen Consumption, Hypoperfusion and Organ Injury After Cardio-pulmonary Bypass

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06930443
Status Recruiting
Phase
Sponsor Uppsala University Hospital
Condition Cardiac Surgery Requiring Cardiopulmonary Bypass
Study Type OBSERVATIONAL
Enrollment 65 participants
Start Date 2025-05-05
Primary Completion 2025-12

Trial Parameters

Condition Cardiac Surgery Requiring Cardiopulmonary Bypass
Sponsor Uppsala University Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 65
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-05-05
Completion 2025-12
Interventions
Oxygen consumption measurement

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this observational study is to understand how oxygen consumption after heart surgery relates to blood flow problems and organ injury. The study focuses on patients over 18 years old who are having planned heart surgery with a heart-lung machine (cardiopulmonary bypass). The main questions the study aims to answer are: 1. How does oxygen consumption in the early hours after surgery relate to lactate levels (a sign of low oxygen supply to the tissues)? 2. How is oxygen consumption linked to signs of poor blood flow and organ injury (such as heart, kidney, liver, brain, and gut damage)? Researchers will measure oxygen consumption after surgery using a technique called indirect calorimetry. They will also track blood flow and oxygen use during surgery and check for signs of organ injury the day after the procedure. The study will include 65 participants. People with certain health conditions, like severe anemia, high lactate levels before surgery, or needing intensive care or extra oxygen supply before surgery, will not be included. By understanding how oxygen consumption relates to blood flow and organ injury, this research may help to better manage patients after heart surgery and reduce complications.

Eligibility Criteria

Inclusion Criteria: * Elective cardiac surgery requiring cardiopulmonary bypass Exclusion Criteria: * Combined, redo or annuloplasty procedures * Surgical procedures involving other vascular cannulation than standard direct, such as bicaval or femoral cannulation * Preoperative hyperlactatemia (\>2mmol/L) or anaemia (Hb \<90 g/dL) * Preoperative need for supplementary oxygen or ICU care * Consent not obtainable.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology